These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 37149980)

  • 21. Nanomedicines: A Focus on Nanomaterials as Drug Delivery System with Current Trends and Future Advancement.
    Pandey J; Dubey R; Kate A; Prasad B; Sinha A; Mishra MS
    Drug Res (Stuttg); 2022 Sep; 72(7):355-366. PubMed ID: 35636435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimalarial drugs: current status and new developments.
    Rathore D; McCutchan TF; Sullivan M; Kumar S
    Expert Opin Investig Drugs; 2005 Jul; 14(7):871-83. PubMed ID: 16022576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin: new life for an old drug.
    Aláez-Versón CR; Lantero E; Fernàndez-Busquets X
    Nanomedicine (Lond); 2017 Jul; 12(14):1727-1744. PubMed ID: 28635544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel drug targets in malaria parasite with potential to yield antimalarial drugs with long useful therapeutic lives.
    Muregi FW; Wamakima HN; Kimani FT
    Curr Pharm Des; 2012; 18(24):3505-21. PubMed ID: 22607143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma.
    Arshad R; Barani M; Rahdar A; Sargazi S; Cucchiarini M; Pandey S; Kang M
    Biosensors (Basel); 2021 Mar; 11(4):. PubMed ID: 33810621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toy kit against malaria: magic bullets, LEGO, Trojan horses and Russian dolls.
    Fernàndez-Busquets X
    Ther Deliv; 2014 Oct; 5(10):1049-52. PubMed ID: 25418263
    [No Abstract]   [Full Text] [Related]  

  • 27. Antimalarial Drug: From its Development to Deface.
    Barik TK
    Curr Drug Discov Technol; 2015; 12(4):225-8. PubMed ID: 26343059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination Therapy Strategies for the Treatment of Malaria.
    Alven S; Aderibigbe B
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31591293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanobiotechnological modules as molecular target tracker for the treatment and prevention of malaria: options and opportunity.
    Anamika J; Nikhar V; Laxmikant G; Priya S; Sonal V; Vyas SP
    Drug Deliv Transl Res; 2020 Aug; 10(4):1095-1110. PubMed ID: 32378173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resisting resistance: is there a solution for malaria?
    Verlinden BK; Louw A; Birkholtz LM
    Expert Opin Drug Discov; 2016; 11(4):395-406. PubMed ID: 26926843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Advances in the Development of Chemotherapeutic Agents for Malaria.
    Shrivastava N; Khan SA; Ahmad S; Al-Balushi K; Husain A
    Mini Rev Med Chem; 2021; 21(12):1487-1508. PubMed ID: 33349215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved antimalarial activity of caprol-based nanostructured lipid carriers encapsulating artemether-lumefantrine for oral administration.
    Akpa PA; Ugwuoke JA; Attama AA; Ugwu CN; Ezeibe EN; Momoh MA; Echezona AC; Kenechukwu FC
    Afr Health Sci; 2020 Dec; 20(4):1679-1697. PubMed ID: 34394228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New medicines to improve control and contribute to the eradication of malaria.
    Wells TN; Alonso PL; Gutteridge WE
    Nat Rev Drug Discov; 2009 Nov; 8(11):879-91. PubMed ID: 19834482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
    Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Design and Application of Nanomaterials as Drug Carriers in Cancer Treatment.
    Hou J; Sun X; Huang Y; Yang S; Liu J; Feng C; Ma J; Chen B
    Curr Med Chem; 2020; 27(36):6112-6135. PubMed ID: 31419927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development.
    Schlitzer M
    ChemMedChem; 2007 Jul; 2(7):944-86. PubMed ID: 17530725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compound antimalarial ethosomal cataplasm: preparation, evaluation, and mechanism of penetration enhancement.
    Shen S; Liu SZ; Zhang YS; Du MB; Liang AH; Song LH; Ye ZG
    Int J Nanomedicine; 2015; 10():4239-53. PubMed ID: 26170661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long circulatory liposomal maduramicin inhibits the growth of Plasmodium falciparum blood stages in culture and cures murine models of experimental malaria.
    Raza M; Bharti H; Singal A; Nag A; Ghosh PC
    Nanoscale; 2018 Jul; 10(28):13773-13791. PubMed ID: 29995025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progress of researches on antimalarial peptides].
    Zhang D; He X; Cao J
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Apr; 35(2):191-198. PubMed ID: 37253570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring Nanotechnologies for the Effective Therapy of Malaria Using Plant-Based Medicines.
    Oga EF; Singh KK
    Curr Pharm Des; 2016; 22(27):4232-46. PubMed ID: 27262326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.